`Patent No. 9,187,405
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`APOTEX INC., APOTEX CORP.,
`ARGENTUM PHARMACEUTICALS LLC,
`ACTAVIS ELIZABETH LLC, AND
`TEVA PHARMACEUTICALS USA, INC.,
`Petitioners,
` v.
`NOVARTIS AG,
`Patent Owner.
`______________________
`Case IPR2017-008541
`U.S. Patent No. 9,187,405
`______________________
`NOTICE OF DEPOSITION OF DR. BARBARA S. GIESSER
`
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
` 1 Cases IPR2017-01550 and IPR2017-01946 have been joined with this
`
`proceeding.
`
` 1
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.53(d), Patent Owner hereby gives notice that it
`
`will take a deposition by oral examination of Dr. Barbara S. Giesser on October 2,
`
`2017, beginning at 9:00 AM (Pacific Time), at the offices of Irell & Manella LLP,
`
`1800 Avenue of the Stars, Suite 900, Los Angeles, California 90067-4276. The
`
`deposition will be recorded stenographically and by video.
`
`
`
`Date: September 26, 2017
`
`
`
`Respectfully submitted,
`
`By:/Jane M. Love, Ph.D./
`Jane M. Love, Ph.D.
`Reg. No. 42,812
`Lead Counsel for Patent Owner
`Gibson, Dunn & Crutcher LLP
`200 Park Avenue
`New York, New York 10166-0193
`jlove@gibsondunn.com
`Tel: 212-351-3922
`
`
`
`2
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on September 26, 2017,
`
`a true and accurate copy of NOTICE OF DEPOSITION OF DR. BARBARA S.
`
`GIESSER was served via electronic mail on the following counsel of record for
`
`Petitioners:
`
`For Apotex:
`
`For Argentum:
`
`
`For Sun:
`
`Steven W. Parmelee: sparmelee@wsgr.com
`Michael T. Rosato: mrosato@wsgr.com
`Jad A. Mills: jmills@wsgr.com
`
`Wilson Sonsini Goodrich & Rosati
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104
`Telephone: 206-883-2542
`
`
`Teresa Stanek Rea: trea@crowell.com
`Deborah H. Yellin: dyelling@crowell.com
`Shannon M. Lentz: slentz@crowell.com
`Tyler C. Liu: TLiu@agpharm.com
`
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Ave, NW
`Washington, DC 20004-2595
`(202) 624-2620
`
`Samuel Park: SPark@winston.com
`Charles B. Klein: CKlein@winston.com
`Sharick Naqi: SNaqi@winston.com
`
`Winston & Strawn LLP
`35 W. Wacker Drive
`Chicago, IL 60601
`3
`
`
`
`
`
`
`
`
`
`
`Telephone: (312) 558-7931
`
`
`For Teva:
`
`
`
`
`Dated: September 26, 2017
`
`Amanda Hollis: amanda.hollis@kirkland.com
`Eugene Goryunov: egoryunov@kirkland.com
`Gregory Springsted: gregory.springsted@kirkland.com
`
`Kirkland & Ellis LLP
`300 North LaSalle
`Chicago, IL 60654
`Telephone: (312) 862-2000
`(202) 624-2620
`
`/Jane M. Love, Ph.D./
`Jane M. Love, Ph.D.
`Reg. No. 42,812
`Lead Counsel for Patent Owner
`Gibson, Dunn & Crutcher LLP
`200 Park Avenue
`New York, New York 10166-0193
`jlove@gibsondunn.com
`Tel: 212-351-3922
`
`4
`
`
`